News Articles

Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People’s Republic of China,... JERSEY CITY, N.J. -Thursday 17 February 2022  

(BUSINESS WIRE) -- Organon (NYSE: OGN) today announced that it has acquired the rights from Bayer AG to Marvelon® and Mercilon®, combined oral hormonal daily contraceptive pills, in the People’s Republic of China, including Hong Kong and Macau, and has entered into an agreement to acquire...

Organon Declares Paid Time Off for All Employees on International Women’s Day; Employees to Focus on Their Own... -Friday 4 February 2022  

(BUSINESS WIRE) -- Organon (NYSE: OGN), a global women’s health company, is designating International Women’s Day (IWD) on March 8 as a day to recognize the growing health disparities women face that have been exacerbated by the COVID-19 pandemic. Since its inception, IWD has focused on...

Organon Completes Acquisition of Forendo Pharma -Tuesday 14 December 2021  

(BUSINESS WIRE)-- Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Forendo Pharma, a clinical-stage drug development company focused on novel treatments in women’s health. Forendo’s lead candidate, FOR-6219, is an...

Organon to Acquire Forendo Pharma -Friday 12 November 2021  

(BUSINESS WIRE)-- Organon (NYSE: OGN), and Forendo Pharma today announced that the companies have entered into a definitive agreement, under which Organon will acquire Forendo, a clinical-stage drug development company focused on novel treatments in women’s health. Forendo is pioneering the...

Organon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy -Tuesday 21 September 2021      

(BUSINESS WIRE)-- Organon (NYSE: OGN), a global women’s health company, is launching a Public Service Announcement (PSA) that aims to raise awareness and ignite a worldwide conversation about the staggering rates of unplanned pregnancy around the world. This press release features...

Organon Completes Acquisition of Alydia Health – A Medical Device Company Focused on Postpartum Hemorrhage -Saturday 19 June 2021  

(BUSINESS WIRE)-- Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal...

Organon Launches as New Global Women’s Health Company -Tuesday 8 June 2021      

(BUSINESS WIRE) -- Organon (NYSE: OGN), today celebrates its launch as a global women’s health company with employees and women from around the world, as the Organon executive leadership team rings the opening bell at the New York Stock Exchange (NYSE). Recognizing the need to listen to and...